文献速递临床试验与 GCP医学人工智能与信息学

基于应用程序的失眠认知行为治疗预防伴有失眠和亚临床抑郁的青少年重性抑郁障碍的效果:一项随机临床试验

Effectiveness of app-based cognitive behavioral therapy for insomnia on preventing major depressive disorder in youth with insomnia and subclinical depression: A randomized clinical trial.
PubMed 文献 · PLoS Med · 2025-01-21

该随机、评估者盲、平行对照试验纳入708名15-25岁伴有失眠障碍和亚临床抑郁症状的中国青少年,1:1分配至6周基于应用程序的失眠认知行为治疗(CBT-I)组或6周基于应用程序的健康教育(HE)组。12个月随访期间,CBT-I组37人(10%) vs HE组62人(18%)新发重性抑郁障碍,风险比HR 0.58(95%CI 0.38-0.87;p=0.008)。CBT-I在改善失眠缓解率和抑郁、失眠症状方面均优于对照组,且未报告干预相关不良事件。

要点

  • 基于应用程序的CBT-I可降低伴有失眠和亚临床抑郁的青少年12个月内新发重性抑郁障碍的风险(HR 0.58)。
  • CBT-I组干预后失眠障碍缓解率52% vs 对照组28%(RR 1.83,95%CI 1.49-2.24;p<0.001)。
  • CBT-I组抑郁和失眠症状改善均优于对照组,失眠是干预影响抑郁的中介因素。

核心结论

  • 基于应用程序的CBT-I可有效预防伴有失眠和亚临床抑郁的青少年未来发生重性抑郁障碍,并改善失眠结局。
  • 作者认为这些发现凸显了针对失眠以预防重性抑郁障碍发作的重要性,并强调需要更广泛地推广数字化CBT-I以促进青少年人群的睡眠和心理健康。

研究设计与样本

  • 随机、评估者盲、平行组对照试验,在中国15-25岁伴有失眠障碍和亚临床抑郁症状的青少年中开展。
  • 参与者按1:1随机分配至6周基于应用程序的CBT-I组或6周基于应用程序的健康教育(HE)组,通过智能手机实施。
  • 在基线、干预后、6个月和12个月随访时进行在线评估和电话临床访谈。
  • 2019年9月9日至2022年11月25日期间,共708名参与者(女性407名[57%];平均年龄22.1岁[SD=1.9])被随机分配至CBT-I组(n=354)或HE组(n=354)。

主要发现

  • 12个月随访期间,CBT-I组37名参与者(10%) vs HE组62名参与者(18%)新发重性抑郁障碍,HR 0.58(95%CI 0.38-0.87;p=0.008)。
  • 预防1例重性抑郁障碍的需治疗人数(NNT)为10.9(95%CI 6.8-26.6)。
  • 干预后CBT-I组失眠障碍缓解率高于对照组(52% vs 28%;RR 1.83[95%CI 1.49-2.24];p<0.001),并在整个12个月随访期间持续高于对照组。
  • 干预后及整个6个月随访期间,CBT-I组抑郁症状(校正差值-1.0[95%CI -1.6至-0.5];Cohen's d=0.53;p<0.001)和失眠症状(校正差值-2.0[95%CI -2.7至-1.3];d=0.78;p<0.001)的下降幅度均大于对照组。
  • 失眠是干预影响抑郁的中介因素;未报告与干预相关的不良事件。

临床怎么用

  • 作者认为基于应用程序的CBT-I可有效预防伴有失眠和亚临床抑郁的青少年未来发生重性抑郁障碍并改善失眠结局。
  • 作者强调需要更广泛地推广数字化CBT-I以促进青少年人群的睡眠和心理健康。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increasing evidence suggests that insomnia plays an important role in the development of depression, supporting insomnia intervention as a promising approach to prevent depression in youth. This randomized controlled trial evaluated the effectiveness of app-based cognitive behavioral therapy for insomnia (CBT-I) in preventing future onset of major depressive disorder (MDD) in youth. METHODS AND FINDINGS: This was a randomized, assessor-blind, parallel group-controlled trial in Chinese youth (aged 15-25 years) with insomnia disorder and subclinical depressive symptoms. Participants were randomly assigned (1:1) to 6-week app-based CBT-I or 6-week app-based health education (HE) delivered through smartphones. Online assessments and telephone clinical interviews were conducted at baseline, post-intervention, 6- and 12-month follow-ups. The primary outcome was time to onset of MDD. The secondary outcomes included depressive symptoms and insomnia at both symptom and disorder levels. Between September 9, 2019, and November 25, 2022, 708 participants (407 females [57%]; mean age, 22.1 years [SD = 1.9]) were randomly allocated to app-based CBT-I group (n = 354) or app-based HE group (n = 354). Thirty-seven participants (10%) in the intervention group and 62 participants (18%) in the control group developed new-onset MDD throughout the 12-month follow-up, with a hazard ratio of 0.58 (95% confidence interval 0.38-0.87; p = 0.008). The number needed to treat to prevent MDD at 1 year was 10.9 (6.8-26.6). The app-based CBT-I group has higher remission rates of insomnia disorder than the controls at post-intervention (52% versus 28%; relative risk 1.83 [1.49-2.24]; p < 0.001) and throughout 12-month follow-up. In addition, the CBT-I group reported a greater decrease in depressive (adjusted difference -1.0 [-1.6 to -0.5]; Cohen's d = 0.53; p < 0.001) and insomnia symptoms (-2.0 [-2.7 to -1.3], d = 0.78; p < 0.001) than the controls at post-intervention and throughout 6-month follow-up. Insomnia was a mediator of intervention effects on depression. No adverse events related to the interventions were reported. CONCLUSIONS: App-based CBT-I is effective in preventing future onset of major depression and improving insomnia outcomes among youth with insomnia and subclinical depression. These findings highlight the importance of targeting insomnia to prevent the onset of MDD and emphasize the need for wider dissemination of digital CBT-I to promote sleep and mental health in the youth population. TRIAL REGISTRATION: ClinicalTrials.Gov (NCT04069247).

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Chen SJ, Que JY, Chan NY, et al. Effectiveness of app-based cognitive behavioral therapy for insomnia on preventing major depressive disorder in youth with insomnia and subclinical depression: A randomized clinical trial. PLoS Med. 2025. PMID: 39836656. doi:10.1371/journal.pmed.1004510

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。